Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients

BMC Pulm Med. 2019 Jun 24;19(1):112. doi: 10.1186/s12890-019-0867-x.

Abstract

Background: The respiratory microbiome is altered in COPD patients but its relationship with core components of the disease, such as the severity of airflow limitation, the frequency of exacerbations or the circulating levels of eosinophils, is unclear.

Methods: Cross-sectional study comprising 72 clinically stable COPD patients (mean age 68 [SD 7.9] years; FEV1 48.7 [SD 20.1]% of reference) who provided spontaneous sputum samples for 16S rRNA gene amplification and sequencing. The microbiome composition was analysed with QIIME.

Results: We observed that: (1) more severe airflow limitation was associated with reduced relative abundance (RA) of Treponema and an increase in Pseudomonas; (2) patients with ≥2 exacerbations the previous year showed a significantly different bacterial community with respect to non-exacerbators (p = 0.014), with changes in 13 genera, including an increase of Pseudomonas, and finally, (3) peripheral eosinophils levels ≥2% were associated with more diverse microbiome [Chao1 224.51 (74.88) vs 277.39 (78.92) p = 0.006; Shannon 3.94 (1.05) vs 4.54 (1.06) p = 0.020], and a significant increase in the RAs of 20 genera.

Conclusion: The respiratory microbiome in clinically stable COPD patients varies significantly according to the severity of airflow limitation, previous history of exacerbations and circulating eosinophils levels.

Keywords: Bacterial community; Diversity; Eosinophils; Exacerbations; Sputum; Stable COPD.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Aged
  • Cross-Sectional Studies
  • Disease Progression
  • Eosinophils / cytology*
  • Female
  • Forced Expiratory Volume
  • Humans
  • Leukocyte Count
  • Lung / physiopathology
  • Male
  • Microbiota*
  • Middle Aged
  • Multivariate Analysis
  • Prospective Studies
  • Pulmonary Disease, Chronic Obstructive / blood*
  • Pulmonary Disease, Chronic Obstructive / microbiology*
  • RNA, Ribosomal, 16S / genetics
  • Respiratory System / microbiology*
  • Severity of Illness Index
  • Sputum / cytology
  • Sputum / microbiology

Substances

  • RNA, Ribosomal, 16S